DOXIPROCT Plus ong tb 20 g

7680389340152 CH-38934 C05AA09 02.09.2.
DOXIPROCT Plus ong tb 20 g
DOXIPROCT Plus ong tb 20 g
DOXIPROCT Plus ong tb 20 g
1 / 3
google

Details

Product number
3893401
CPT
-
Packaging group
20
Unit
g
Composition
calcii dobesilas monohydricus 40 mg, lidocaini hydrochloridum monohydricum 20 mg, dexamethasoni acetas 0.25 mg, polysorbatum 80, macrogolum 300, macrogolum 1500, macrogolum 4000, acidum citricum, alcohol cetylicus 60 mg, propylenglycolum 309 mg, E 310, E 320 150 µg, ad unguentum pro 1 g.

Articles (1)

Doxiproct Plus, pommade rectale
pommade rectale
20
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
02/06/2025
Patient information leaflet
Français
02/06/2025
Patient information leaflet
Italien
02/06/2025
Professional SmPC
Allemand
02/06/2025
Professional SmPC
Français
02/06/2025
Professional SmPC
Italien
02/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
0.25 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
60.0 MG Substance HBESI
(N/A)
309.0 MG Substance HBESI
(N/A)
- Substance ANTOX
(N/A)
150.0 UG Substance HBESI

Authorization holder

OM Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
38934
Drug name
Doxiproct Plus, pommade rectale
Galenic form
REKS
ATC Code
C05AA09
Authorization status
Z
Dispensation category
B
First authorization
22/04/1975
Authorization expiration date
31/12/9999
IT number
02.09.2.
Domain
Human medicine

Packaging details

Description (FR)
DOXIPROCT Plus ong tb 20 g
Description (DE)
DOXIPROCT Plus Salbe Tb 20 g
Market launch
22/04/1975
Narcotic (BTM)
No